ACET logo

ACET
Adicet Bio Inc

3,732
Mkt Cap
$71.79M
Volume
138,861.00
52W High
$17.44
52W Low
$6.01
PE Ratio
-0.51
ACET Fundamentals
Price
$7.68
Prev Close
$8.41
Open
$8.25
50D MA
$7.46
Beta
1.08
Avg. Volume
142,915.84
EPS (Annual)
-$16.95
P/B
0.53
Rev/Employee
$0.00
$85.77
Loading...
Loading...
News
all
press releases
Adicet Bio to Participate in Fireside Chat at Jefferies Global Healthcare Conference
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that...
Business Wire·3d ago
News Placeholder
More News
News Placeholder
Adicet Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial...
Business Wire·4d ago
News Placeholder
Johnson & Johnson Sells 341,693 Shares of Adicet Bio, Inc. $ACET
Johnson & Johnson lessened its stake in Adicet Bio, Inc. (NASDAQ:ACET - Free Report) by 93.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 22,779 shares of the company's stock after selling 341,693 shares during the quart...
MarketBeat·14d ago
News Placeholder
Adicet Bio (ACET) Expected to Announce Quarterly Earnings on Tuesday
Adicet Bio (NASDAQ:ACET) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at...
MarketBeat·19d ago
News Placeholder
Adicet Bio, Inc. (NASDAQ:ACET) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Shares of Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold ra...
MarketBeat·26d ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Stock Passes Below Two Hundred Day Moving Average - Here's Why
Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below 200-Day Moving Average - Time to Sell...
MarketBeat·27d ago
News Placeholder
Ra Capital Management, L.P. Buys 74,751 Shares of Adicet Bio (NASDAQ:ACET) Stock
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. purchased 74,751 shares of the business's stock in a transaction on Friday, February 20th. The shares were acquired at an average price of $7.27 per share, with a total value of $543,439.77. Following the...
MarketBeat·1mo ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Major Shareholder Purchases $535,472.28 in Stock
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. purchased 74,268 shares of the company's stock in a transaction on Thursday, February 19th. The shares were bought at an average price of $7.21 per share, with a total value of $535,472.28. Following the...
MarketBeat·1mo ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Major Shareholder Ra Capital Management, L.P. Acquires 74,577 Shares
Adicet Bio, Inc. (NASDAQ:ACET - Get Free Report) major shareholder Ra Capital Management, L.P. bought 74,577 shares of the stock in a transaction on Wednesday, February 18th. The stock was purchased at an average price of $7.04 per share, for a total transaction of $525,022.08. Following the...
MarketBeat·1mo ago
News Placeholder
Adicet Bio (NASDAQ:ACET) Stock Price Crosses Below Two Hundred Day Moving Average - Should You Sell?
Adicet Bio (NASDAQ:ACET) Stock Passes Below 200-Day Moving Average - What's Next...
MarketBeat·1mo ago
<
1
2
...
>

Latest ACET News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.